Please use this identifier to cite or link to this item:
http://hdl.handle.net/11718/24077
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2021-06-26T10:08:43Z | - |
dc.date.available | 2021-06-26T10:08:43Z | - |
dc.date.issued | 2021-06-26 | - |
dc.identifier.uri | http://hdl.handle.net/11718/24077 | - |
dc.language.iso | en_US | en_US |
dc.publisher | Business Standard | en_US |
dc.subject | PharmEasy | en_US |
dc.subject | Siddharth Shah | en_US |
dc.subject | IIMA alumni | en_US |
dc.subject | API holdings | en_US |
dc.title | PharmaEasy buys 66% in Thyrocare for ₹4,500 crore | en_US |
dc.type | Newspaper | en_US |
Appears in Collections: | IIMA In Media |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
BS_26_JUNE_2021_AHMEDABAD-1.jpg | BS_26_JUNE_2021_AHMEDABAD-1 | 1.03 MB | JPEG | View/Open |
Items in IIMA Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated.